New rules would change how homeopathic drugs are made, labeled, and sold to consumers.
This bill would create a separate set of rules for homeopathic drug products, affecting how they are made, tested, and labeled. It aims to ensure continued access to these products while requiring clearer safety and quality standards for manufacturers and more transparent information for consumers. The Food and Drug Administration (FDA) would need to create new regulations and withdraw its current guidance on these products.
Today, homeopathic drug products are regulated under general food and drug laws, and the FDA has specific guidance for them. This bill would create a separate legal pathway for homeopathic drugs, setting new definitions, manufacturing standards, and labeling rules, and would get rid of the current FDA guidance published in December 2022.
HR 7050 · 119th Congress · January 14, 2026 · AI Summary by gemini-2.5-flash · 10/10
Sign in to see your representatives' phone numbers
3 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.